A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy

Schmitt, C.A., Fridman, J.S., Yang, M., Lee, S., Baranov, E., Hoffman, R.M., &amp; Lowe, S.W. (2002). A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy. <em>Cell</em>. https://doi.org/10.1016/s0092-8674(02)00734-1

Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, et al. A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy. Cell. 2002. doi:10.1016/s0092-8674(02)00734-1.

@article{clemens2002ASenes, title = {A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy}, author = {Clemens A. Schmitt and Jordan S. Fridman and Meng Yang and Soyoung Lee and Eugene Baranov and Robert M. Hoffman and Scott W. Lowe}, journal = {Cell}, year = {2002}, doi = {10.1016/s0092-8674(02)00734-1}, }